EnBio Holdings Statistics

Total Valuation

EnBio Holdings has a market cap or net worth of JPY 4.72 billion. The enterprise value is 11.61 billion.

Market Cap	4.72B
Enterprise Value	11.61B

Important Dates

The last earnings date was Thursday, May 15, 2025.

Earnings Date	May 15, 2025
Ex-Dividend Date	Mar 28, 2025

Share Statistics

EnBio Holdings has 8.08 million shares outstanding. The number of shares has increased by 1.52% in one year.

Current Share Class	8.08M
Shares Outstanding	8.08M
Shares Change (YoY)	+1.52%
Shares Change (QoQ)	+0.04%
Owned by Insiders (%)	19.67%
Owned by Institutions (%)	5.07%
Float	3.65M

Valuation Ratios

The trailing PE ratio is 10.46.

PE Ratio	10.46
Forward PE	n/a
PS Ratio	0.44
PB Ratio	0.51
P/TBV Ratio	0.54
P/FCF Ratio	n/a
P/OCF Ratio	224.75
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 8.63, with an EV/FCF ratio of -8.06.

EV / Earnings	25.69
EV / Sales	1.09
EV / EBITDA	8.63
EV / EBIT	13.69
EV / FCF	-8.06

Financial Position

The company has a current ratio of 1.86, with a Debt / Equity ratio of 1.09.

Current Ratio	1.86
Quick Ratio	1.17
Debt / Equity	1.09
Debt / EBITDA	7.51
Debt / FCF	-7.01
Interest Coverage	6.01

Financial Efficiency

Return on equity (ROE) is 4.71% and return on invested capital (ROIC) is 2.90%.

Return on Equity (ROE)	4.71%
Return on Assets (ROA)	2.62%
Return on Invested Capital (ROIC)	2.90%
Return on Capital Employed (ROCE)	5.18%
Revenue Per Employee	102.58M
Profits Per Employee	4.35M
Employee Count	104
Asset Turnover	0.53
Inventory Turnover	2.74

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -2.19% in the last 52 weeks. The beta is 0.76, so EnBio Holdings's price volatility has been lower than the market average.

Beta (5Y)	0.76
52-Week Price Change	-2.19%
50-Day Moving Average	579.04
200-Day Moving Average	595.89
Relative Strength Index (RSI)	51.88
Average Volume (20 Days)	6,290

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, EnBio Holdings had revenue of JPY 10.67 billion and earned 452.00 million in profits. Earnings per share was 55.81.

Revenue	10.67B
Gross Profit	2.65B
Operating Income	848.00M
Pretax Income	701.00M
Net Income	452.00M
EBITDA	1.35B
EBIT	848.00M
Earnings Per Share (EPS)	55.81

Full Income Statement

Balance Sheet

The company has 3.29 billion in cash and 10.10 billion in debt, giving a net cash position of -6.80 billion or -841.90 per share.

Cash & Cash Equivalents	3.29B
Total Debt	10.10B
Net Cash	-6.80B
Net Cash Per Share	-841.90
Equity (Book Value)	9.23B
Book Value Per Share	1,130.66
Working Capital	4.14B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 21.00 million and capital expenditures -1.46 billion, giving a free cash flow of -1.44 billion.

Operating Cash Flow	21.00M
Capital Expenditures	-1.46B
Free Cash Flow	-1.44B
FCF Per Share	-178.30

Full Cash Flow Statement

Margins

Gross margin is 24.88%, with operating and profit margins of 7.95% and 4.24%.

Gross Margin	24.88%
Operating Margin	7.95%
Pretax Margin	6.57%
Profit Margin	4.24%
EBITDA Margin	12.61%
EBIT Margin	7.95%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 8.00, which amounts to a dividend yield of 1.38%.

Dividend Per Share	8.00
Dividend Yield	1.38%
Dividend Growth (YoY)	12.50%
Years of Dividend Growth	n/a
Payout Ratio	14.38%
Buyback Yield	-1.52%
Shareholder Yield	-0.14%
Earnings Yield	9.58%
FCF Yield	-30.53%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

EnBio Holdings has an Altman Z-Score of 1.39. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.39
Piotroski F-Score	n/a